Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christer Allgulander

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|July 26, 2007
[What our patients want and need to know about generalized anxiety disorder]Christer Allgulander
The Psychiatric Clinics of North America|September 1, 2009
Generalized anxiety disorder: between now and DSM-VChrister Allgulander
Current Opinion in Psychiatry|November 18, 2015
Anxiety as a risk factor in cardiovascular diseaseChrister Allgulander
Lakartidningen|August 6, 2003
[Do you treat patients with Seroxat?]Christer Allgulander
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 30, 2006
Generalized anxiety disorder: What are we missing?Christer Allgulander
Current Opinion in Psychiatry|November 6, 2009
Novel approaches to treatment of generalized anxiety disorderChrister Allgulander
Psychopharmacology Bulletin|December 20, 2002
Coping with somatic comorbidities: striving for complete recoveryChrister Allgulander, Siegfried Kasper
Lakartidningen|April 12, 2003
[A nationwide study in primary health care: One out of four patients suffers from anxiety and depression]Christer Allgulander, Bo Nilsson
Lakartidningen|November 25, 2011
[Benefits and risks of benzodiazepines. A current analysis of facts]Christer Allgulander, Mussie Msghina
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 29, 2011
Antipsychotics in anxiety disorders: an oxymoron or a reflection of non-adequate nomenclature?Joseph Zohar, Christer Allgulander
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|July 26, 2007
[What our patients want and need to know about generalized anxiety disorder]Christer Allgulander
The Psychiatric Clinics of North America|September 1, 2009
Generalized anxiety disorder: between now and DSM-VChrister Allgulander
Current Opinion in Psychiatry|November 18, 2015
Anxiety as a risk factor in cardiovascular diseaseChrister Allgulander
Lakartidningen|August 6, 2003
[Do you treat patients with Seroxat?]Christer Allgulander
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 30, 2006
Generalized anxiety disorder: What are we missing?Christer Allgulander
Current Opinion in Psychiatry|November 6, 2009
Novel approaches to treatment of generalized anxiety disorderChrister Allgulander
Psychopharmacology Bulletin|December 20, 2002
Coping with somatic comorbidities: striving for complete recoveryChrister Allgulander, Siegfried Kasper
Lakartidningen|April 12, 2003
[A nationwide study in primary health care: One out of four patients suffers from anxiety and depression]Christer Allgulander, Bo Nilsson
Lakartidningen|November 25, 2011
[Benefits and risks of benzodiazepines. A current analysis of facts]Christer Allgulander, Mussie Msghina
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 29, 2011
Antipsychotics in anxiety disorders: an oxymoron or a reflection of non-adequate nomenclature?Joseph Zohar, Christer Allgulander
Pageof 6